74° Mostly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PAVmed Inc. - Common Stock (NQ:PAVM)

2.950 +0.250 (+9.26%)

Delayed Quote Updated: 11:02 AM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PAVmed Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

November 16, 2021

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

Earnings Scheduled For November 16, 2021 ↗

November 16, 2021

Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

November 11, 2021

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021

November 03, 2021

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

Veris Health Showcased in PAVmed Digital Health Virtual Investor Event

October 29, 2021

From PAVmed Inc.

Via Business Wire

Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award

October 28, 2021

From Lucid Diagnostics Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 27, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX...

Via Benzinga

PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer

October 25, 2021

From PAVmed Inc.

Via Business Wire

ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

October 21, 2021

From Lucid Diagnostics Inc.

Via Business Wire

Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

October 21, 2021

From Lucid Diagnostics Inc.

Via Business Wire

Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

October 18, 2021

From Lucid Diagnostics Inc.

Via Business Wire

44 Biggest Movers From Yesterday ↗

October 15, 2021

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...

Via Benzinga

PAVM Stock: One Big Reason Why PAVmed Is Plunging Today ↗

October 14, 2021

Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 14, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP...

Via Benzinga

The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts ↗

October 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc...

Via Benzinga

Lucid Diagnostics Announces Pricing of Initial Public Offering

October 13, 2021

From PAVmed Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

PAVmed Acquires EsophaCap Manufacturer CapNostics LLC

October 07, 2021

From PAVmed Inc.

Via Business Wire

PAVmed to Host Digital Health Virtual Investor Event

September 30, 2021

From PAVmed Inc.

Via Business Wire

58 Biggest Movers From Yesterday ↗

September 24, 2021

Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362...

Via Benzinga

Why PAVmed Shares Are Trading Higher Today ↗

September 23, 2021

PAVmed Inc (NASDAQ: PAVM) is trading higher Thursday after the company announced its majority-owned subsidiary, Lucid Diagnostics, filed a registration statement for a...

Via Benzinga

These 2 Nasdaq Small Caps Just Got Big Boosts ↗

September 23, 2021

In a rising market, these companies looked especially impressive.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 23, 2021

Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 94.3% to $5.09 during Thursday's regular session. TransCode Therapeutics's stock is trading at a volume of...

Via Benzinga

PAVmed's Subsidiary, Lucid Diagnostics Files For $58M IPO ↗

September 23, 2021

Lucid Diagnostic, a maker of diagnostic tests for esophageal precancer and cancer, filed to raise up to $58 million in an ...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

September 23, 2021

Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares jumped 101% to $14.87 following news the company will buy ZACC Kabushiki Kaisha for $3.362 million. TransCode...

Via Benzinga

PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering

September 23, 2021

From PAVmed, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 23, 2021

Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 23.66% to $3.24 during Thursday's pre-market session. The company's market cap stands at $41.8...

Via Benzinga

24 Stocks Moving in Thursday's Pre-Market Session ↗

September 23, 2021

Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

PAVmed Inc. - Common Stock (NQ:PAVM)

All News about PAVmed Inc. - Common Stock

Sections

Services